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The idea of in vivo measurement of biological and/or
biochemical processes was already envisaged in the 1930’s
when the first artificially produced radionuclides of the
biologically important elements carbon, nitrogen and
oxygen were discovered with help of the then recently
developed cyclotron. These radionuclides decay by pure
positron emission and the annihilation of positron and
electron results in two 511 keV γ-quanta under a relative
angle of about 180o, which are measured in coincidence.
This idea of PET could only be realized when the inorganic
scintillation detectors for the detection of γ-radiation,
electronics for the coincidence measurements and the
computer capacity for data acquisition and image recon-
struction became available. For this reason the technical
development of Positron Emission Tomography [6] as a fun-
ctional in vivo imaging discipline began just over 30 years
ago.
PET employs mainly short-lived positron emitting
radiopharmaceuticals. The most widely used radionu-
clides are: 11C (t1/2 = 20.38 min), 
13N (t1/2 = 9.96 min), 
15O
(t1/2 = 2.03 min) and 
18F (t1/2 = 109.7 min). Carbon, oxygen,
nitrogen and hydrogen are the elements of life and the
building blocks of nearly every molecule of biological
importance. However, hydrogen has no radioactive isotope
decaying with the emission of radiation which can be
detected outside the human body. For this reason, the
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Abstract Positron Emission Tomography (PET) is a method for determining biochemical and physiological processes in vivo
in a quantitative manner. The most commonly used radionuclides are 11C, 13N, 15O and 18F, with respective half-lives of
approximately 20 min, 10 min, 2 min, and 110 min. 18F labeled FDG (fluoro-2-deoxy-D-glucose) is now the most frequently
used radiopharmaceutical and finds its application prominently in the field of oncology. Originally, the production of these
radionuclides was performed with the existing accelerators, designed for nuclear physics, but with increasing interest in the
PET methodology specially designed PET-production cyclotrons became available. The nuclear reactions involved are (p,n),
(d,n), (p,α) and (d,α) and the thresholds for the nuclear reactions involved are 5 to 6 MeV.  Based on these values and on other
parameters, a proton 15 to 20 MeV cyclotron is often chosen. Since the half-life of a radionuclide limits the production time,
the maximum beam current is an important parameter, together with the target construction, for the ultimate yield obtainable.
In the development of special PET production cyclotrons, attention has also been paid to improve the extraction efficiency and
the possibility of multiple extractions by designing negative ion cyclotrons. Commercial cyclotrons can often be acquired as an
easy to operate integrated radionuclide production unit including targetry and some  units. Regional FDG factories are nowadays
being created to fulfil the demand for PET radiopharmaceutics. The possible choices in commercially available cyclotrons for
the production of PET radionuclides will be discussed.
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fluorine-18 isotope is often used to replace a hydrogen atom
in a molecule. Due to these short half-lives the radionuclides
have to be produced in-house, preferably with a small,
dedicated cyclotron. Since the chemical form of accelerator
produced radionuclides can only be simple, input from
organic- and radiochemistry is essential for synthesis of the
desired complex molecules [1, 2]. Their final formulation
and the evaluation of pharmacokinetic studies lie in the
domain of pharmacy. Medical science is applied in the evalu-
ation of the clinical application with respect to the radio-
pharmaceuticals used.
Nuclear reactions and specific activity
For the production of the four most essential PET
radionuclides low energy cyclotrons (Ep < 20 MeV) are
sufficient, as can be seen from Table 1 where the nuclear
reaction involved, the Q-values, the target materials and
the chemical form of the produced radionuclide are
summarized [3, 5]. Sometimes oxygen or fluorine gas is
added to the target gas in order to obtain the produced
radioactivity in the desired chemical form. By this addition
the specific activity, see below, will be lowered.
Nowadays, small dedicated cyclotrons are commercially
available. These accelerators are one- or two-particle
machines, mostly with fixed energies. Mostly negative-
ion machines are being installed because of their relatively
simple extraction system and high extraction efficiency.
They are installed complete with the targetry for making
the four above-mentioned short-lived radionuclides in
batches of up to 100 GBq or higher. Also, the chemistry
for some simple chemical products is incorporated, e.g.
11CO2, 
11CO, C15O, C15O2, H2
15O etc. Sometimes synthesis
modules for the preparation of more complex molecules,
e.g. 18FDG, 18F-DOPA, H11CN, 11CH4, 
11CH3I or 
13NH3,
are also available from the cyclotron manufacturer or from
another specialized company. These products become
available via dedicated, automated systems or via a pro-
grammable robotic system. Production of other radiophar-
maceuticals has to be set-up individually in each PET center.
Due to the nature of the induced nuclear reaction (p,n),
(d,n), (p,α) or (d,α) there is a change in element:
    Z → Z + 1  or  Z → Z − 1
The term “carrier free” is used when no “cold” material
of the same chemical composition as the radioactive species
is present. This is very difficult to achieve because often
natural dilution occurs. Contamination, to the order of a
few ppm is very difficult to avoid. Often the term “no carrier
added” production is used. This means no “cold” material
of the same chemical identity is added on purpose by the
investigator during preparation of the radiopharmaceutical.
Specific activity is the amount of radioactivity per gram
or mole. The theoretical maximum of the specific activity
is related to the number of radionuclides A (Bq) = Noλ
with λ = ln2/t1/2 the decay constant. The maximum specific
activity for 11C of 340 TBq/µmol vs. the specific activity of
14C of 2.3 MBq/mmol is completely explained by the
difference in their half-lives, 20.4 min vs. 5730 yrs. In reality,
the theoretical maxima in specific activity are never
reached. Very special precautions have to be taken to keep
the dilution factor low; e.g. the target should not be opened,
always kept pressurized, target materials should be selected
on the basis of their contaminations with ppm amounts of
non-desired elements etc. With a carrier free or no carrier
added synthesis one expects no toxic effects (e.g. H11CN
or C15O are toxic no more) nor any physiological effects
(tracer principle). Radiopharmaceuticals with a high
specific activity are essential in the case of studies of
receptor systems such as, e.g., the dopaminergic system.
Accelerators for PET radionuclide production
In the proton energy range from 10−20 MeV all four basic
radionuclides: 11C, 13N, 15O and 18F, can be produced.
A deuteron beam of 5−10 MeV is prefered for the produc-
tion of 15O and sometimes 18F in the molecular form. In
general, the device of choice is a cyclotron, not a linear
accelerator, because in this energy range the cyclotron is
a more versatile and economic solution. Although at higher
energies a larger part of the excitation function can be
exploited resulting in a higher yield, some companies have
purposely designed cyclotrons of proton energy range of
10−11 MeV, for economic reasons. In Table 2 an overview
is given of the commercially available cyclotrons with
10 MeV < Ep < 20 MeV. The requirements imposed on
a radionuclide production machine differ from those
imposed on machines designed for experimental nuclear
physics. For radionuclide production beam quality par-
ameters such as momentum resolution or beam emittance
are less important. On the other hand, a high beam current
distributed over a larger (cm2 instead of mm2) beam spot
is essential for achieving a high radionuclide production
rate. Technical descriptions of these cyclotrons are available
from the respective manufacturers. All these cyclotrons are
negative ion machines. The operation of this class of cyclo-
trons is most often done by the radiochemists, and no
special operator group is required. For daily operation and
maintenance, obviously, the required knowledge has to be
available.
The target systems are mostly installed just at the beam
exit of the cyclotron. Sometimes a short beam line is
installed to focus the beam on the target. The big advantage
of negative ions is that after passing through a carbon
stripper foil, all electrons are removed and the beam is
automatically bended out of the machine. Extraction

















   * Direct production of ammonia is possible by adding ethanol to water.
Table 1. Nuclear reactions and target products for the four
important PET radionuclides.
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efficiency of 100% is possible and by positioning the
stripper foil partially intercepting the beam, also multiple
(at least 2) extracted beams are available. With short-lived
radionuclides the maximum beam current a target can
withstand under irradiation conditions is the crucial
parameter for the yield obtainable. An irradiation time of
two half-lives produces 75% of the saturation value (the
saturation yield is defined as the yield (GBq/µA) at infinite
irradiation time). So, increasing the beam current or
increasing the beam energy are the only two possibilities
to increase the yield. Increasing the beam current gives
a linear increase in yield as long as the target can withstand
the heat dissipation. Increasing the beam energy will
increase the yield but this depends on the actual values of
the excitation function of the nuclear reaction used. For
production of 18F by the proton induced reaction on 18O,
a factor of nearly 2 can be gained in yield, the saturation
yield increasing from about 4 GBq/µA at Ep = 10 MeV
to roughly 7.5 GBq/µA at Ep = 20 MeV. Hence, the lower
the energy, the higher is the required beam current for the
same yield and the more critical is the target construction.
Since also the energy losses in the respective foils will be
higher at lower energies, the target construction will become
even more critical. Sometimes, simultaneous irradi-
ation of two targets is possible in negative ion cyclotrons.
Targets for the production of the four essential radio-
nuclides are also commercially available and often the
installation of a cyclotron is a turn-key project comprising
of the targets, transport of the radionuclides and some
radiochemistry units for the production of radiophar-
maceuticals.
The transport of irradiated material can be very easy in
the case of a gas target. Just a normal flow can carry the
radioactivity over 50−100 m, but a distance of 500 m is
possible in a well tuned pipeline [4]. In the case of a fluid
target, a flow of helium through thin tubing can move the
irradiated material into the desired position. With solid
targets an exchange system or train system can transport
the target or target material. The local situation will dictate
which particular solution is most appropriate.
Targetry
For reliable operation not only a reliable cyclotron but also
reliable targets are needed. The targets often need to be
adapted to the specific beam size and beam energy used.
On the front side often a double foil technique is used.
The first foil separates the target from vacuum, helium is
circulated between the two foils to cool the foils, and the
second foil separates the target material from the helium
cooling. The beam size is adapted to the size of the target
or vice versa, but the beam size should not be too small
because too high a power dissipation (W/cm2) will cause
foil rupture. The foil material is often stainless steel or
Havar, of thickness between 10 and 25 µm. In these target
foils, longer living radionuclides such as e.g. 57Co will be
produced. Under normal conditions the lifetime of a foil
is typically around 2000 µAh. The target body itself is often
made of aluminium. Practically no long-lived radionuclides
can be produced in aluminium, and is easy to machine.
Chemistry can dictate other target materials, such as
titanium or niobium. On the back-side of the target water
cooling is supplied. If enriched materials are used, e.g.
H2
18O, the volume will be minimized while the yield or
beam current has to be maximized. These requirements
determine the target design. Most cyclotron manufacturers
will supply  their own target designs but targets can also be
purchased from specialized companies. The cyclotron and
the target have to form a reliable combination and, as
already stated before, by lowering the beam energy the
production yield can only be maintained by increasing
the beam current onto the target.
Shielding
Normally a cyclotron is placed in a vault made of standard
concrete (density 2.35 g/cm3). The thickness is determined
by the estimated flux of neutron and gamma radiation and
is in accordance with the local radiation safety regulations,
but generally the thickness will be around 1.5 m [7, 8]. Some
Table 2. Commercially available cyclotrons
with 10 MeV < Ep < 20 MeV.
Company Type Particle Ep/Ed (MeV) Ip (µA) Id (µA)
CTI RDS111 H− 11/na 2 × 40 na
Eclipse H− 11/na 2 × 60 na
EBCO TR14(19*) H− 14/na >100 na
TR19 H− 11−19/9**** >200 >100
GE MINItrace H− 10/na yield** na
PETtrace H−,D− 16.5/8.4 >75 >60
IBA 10/5 H−,D− 10/5 >60    35
18/9 H−,D− 18/9 >80 >35
Sumitomo*** HM-12 H−,D− 12/6    80    30
HM-18 H−,D− 18/10 >70 >50
MINItrace H− 10/na yield** na
  The companies involved are CTI Inc., Knoxville (TN), USA; EBCO Technologies Inc.,
Richmond (BC) Canada; GE, Milwaukee (WI), USA; IBA, Louvain-la-Neuve, Belgium and
Sumimoto Heavy Industries Ltd, Tokyo, Japan.
   * The EBCO TR14 is upgradable to a TR19.
   ** Instead of current the yield is specified.
   *** The Sumimoto cyclotrons are not marketed in Europe.
   **** The 9 MeV deuteron beam is optional.
   na − not applicable.
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companies also offer a local shielding by placing concrete
and lead as a jacket around the cyclotron, see Table 3.
Cyclotrons with this type of local shielding are sometimes
advertised as “self-shielded” cyclotrons. The main advan-
tage is that the total weight will be lower than that of
a vault. The choice between the two options will depend
on the local situation.
Conclusions
The decisive parameters in acquiring a cyclotron for the
four most used PET radionuclides  i.e. 11C, 13N, 15O and
18F are:
−  H− or H−/D− cyclotron;
−  Beam energy, Ep = 10 MeV and Ep = 20 MeV are the
extreme values;
−  Target technology: what is the yield in combination with
the cyclotron, is the transport of product to a radio-
chemical laboratory included?
−   What is the type of shielding, do the authorities approve,
what licenses are required?
−  Are radiopharmaceutical units included, do the author-
ities approve of the production procedures, what licenses
are required?
−  Service contract, what is necessary in the individual case?
− Estimated cost of the whole package;
− Reliability, how reliable is the total production chain
delicered? (at least >90% is recommended).
If a more versatile radionuclide production cyclotron is
desired, a 30 MeV proton cyclotron has to be considered.
References
  1. Elsinga PH (2002) Radiopharmaceutical chemistry for posi-
tron emission tomography. Methods 27:208−217
  2. Friedlander G, Kennedy JW, Macias JM, Miller JM (1981)
Nuclear radiochemistry, 3rd ed. John Wiley & Sons, New
York
  3. Helus F (ed.) (1983) Radionuclides production. Vols 1−2.
CRC Press, Boca Raton
  4. Hichwa RD, Nickles RJ (1979) The tuned pipeline − a link
between small accelerators and nuclear medical needs. IEEE
Trans Nucl Sci 26:1707−1709
  5. IAEA (2001) Charged particle cross-section database for
medical radioisotope production: diagnostic radioisotopes
and monitor reactions. TECDOC Series no. 1211. IAEA,
Vienna
  6. Paans AMJ, van Waarde A, Elsinga PH, Willemsen ATM,
Vaalburg W (2002) Positron emission tomography: the
conceptual idea using a multidisciplinary approach. Methods
27:195−207
  7. Taylor LS (1977) Radiation protection design guidelines for
0.1−100 MeV particle accelerator facilities. Report no. 51.
National Council on Radiation Protection and Measure-
ments (NCRP)
  8. Thomas RH, Stevenson GR (1988) Radiological safety
aspects of the operation of proton accelerators. TECDOC
Series no 283. IAEA, Vienna
Table 3. Shielding for commercial cyclotrons with Ep < 20 MeV.
Cyclotron Vault Local shielding
CTI RDS111 optional standard
Eclipse optional standard
EBCO TR14/TR19 yes optional
GE PETtrace yes no
MINItrace standard
IBA 10/5-18/9 yes optional
Sumimoto HM-18 yes no
HM-12 yes optional
MINItrace standard
